Home > Financial Ratios > KOPRAN

KOPRAN
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results

KOPRAN Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 62.27-44.02-1.77110.80-4.18

What is the latest Core EBITDA Growth ratio of KOPRAN ?

The latest Core EBITDA Growth ratio of KOPRAN is 62.27 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202462.27
Mar2023-44.02
Mar2022-1.77
Mar2021110.80
Mar2020-4.18

How is Core EBITDA Growth of KOPRAN Trending?

Years Core EBITDA Growth % Change
Mar2024 62.27
Positive
Mar2023 -44.02
Negative
Mar2022 -1.77
Negative
Mar2021 110.8
Positive
Mar2020 -4.18 -

Other Financial Ratios of KOPRAN


Compare Core EBITDA Growth ratio of peers of KOPRAN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KOPRAN ₹775.5 Cr NA -9.8% -35.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,917.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,982.0 Cr -6.6% -12.4% 22.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,306.0 Cr 0.7% 9.1% 7.2% Stock Analytics
CIPLA ₹121,442.0 Cr 0.3% 1.2% -5.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,752.0 Cr 0.4% -2.8% -12.7% Stock Analytics


KOPRAN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN NA

-9.8%

-35.7%

SENSEX

-0.5%

-3.1%

1.4%


You may also like the below Video Courses